ADIAL PHARMACEUTICALS, INC. (ADIL) Stock Profile — Insider Trades & Financials

Net Income-$2.0M

EPS$-0.45

Market Cap$2.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Cary Claiborne

CEO & Executive Director

Company profile for Adial Pharmaceuticals, Inc. (ADIL) stock, with a description, list of executives, contact details and other key facts.

Founded: 2010
Employees: 1
Headquarters: Glen Allen, VA, United States
Website: adial.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-37.83%

ROA?

-29.91%

D/E Ratio?

0.26

📊

Profitability Ratios

Current Ratio?

4.42

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 3, 2026 (in 118 days)

Annual Report (10-K) — Based on filing pattern

Aug 3, 2026

Predicted10-K

Mar 5, 2026

10-KQ4 20251d after period end

Nov 13, 2025

10-QQ3 20256d after period end

Aug 13, 2025

10-QQ2 20255d after period end

May 14, 2025

10-QQ1 20251d after period end

Mar 4, 2025

10-KQ4 20244d after period end

Nov 13, 2024

10-QQ3 20241d after period end

Aug 13, 2024

10-QQ2 20241d after period end

Apr 1, 2024

10-KQ4 20233d after period end

Loading company sections...

ADIAL PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness